Impact on Informed Choice of Offering Antenatal Sickle Cell and Thalassaemia Screening in Primary Care: A Randomized Trial | Zendy

Katrina Brown | Zendy; Elizabeth Dormandy | Zendy; Erin Reid | Zendy; Martin Gulliford | Zendy; Theresa M. Marteau | Zendy

Open Access

Impact on Informed Choice of Offering Antenatal Sickle Cell and Thalassaemia Screening in Primary Care: A Randomized Trial

Author(s) -

Katrina Brown,

Elizabeth Dormandy,

Erin Reid,

Martin Gulliford,

Theresa M. Marteau

Publication year - 2011

Publication title -

journal of medical screening

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.515

H-Index - 64

eISSN - 1475-5793

pISSN - 0969-1413

DOI - 10.1258/jms.2011.010132

Subject(s) - medicine , pregnancy , randomized controlled trial , family medicine , informed consent , intervention (counseling) , primary care , cluster randomised controlled trial , test (biology) , psychological intervention , pediatrics , nursing , alternative medicine , paleontology , genetics , pathology , biology

Offering antenatal sickle cell and thalassaemia (SCT) screening early in pregnancy can maximize the range of post-screening choices available, however these benefits should not be obtained at the expense of informed choice. This study examined whether offering this screening in primary care at the time of pregnancy confirmation compromises women making informed choices. Design Partial factorial, cluster randomized controlled trial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research